| Size & multiples | |||
| Market Cap | $377.2M | Enterprise Value | $790.5M |
| P/E (TTM) | 7.86× | PEG (trailing) | — |
| P/S | 0.56× | P/FCF | 2.79× |
| EV/EBITDA | 5.11× | EV/EBIT | 13.02× |
| EV/Sales | 1.17× | EV/FCF | 5.84× |
| FCF Yield | 35.90% | Buyback Yield | 8.99% |
| Owner Earnings (TTM) | $72.7M | Owner Earnings Yield | 19.28% |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 2.35 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 15.77% |
| After-tax Cost of Debt | 6.16% | Synthetic credit rating | CC |
| Cost of Debt · embedded (pre-tax) | 9.69% | Cost of Debt · marginal (synthetic) | 16.61% |
| WACC | 9.97% | ROIC | 6.57% |
| EVA Spread (ROIC−WACC) | −3.40% | EVA | -$30.3M |
FCF runs above owner earnings — under-maintenance or a working-capital release is flattering current cash.
Synthetic rating = ICR-based credit-quality read (Damodaran), not an agency rating.
Flows TTM (last 4 quarters); latest annual for: EPS (Diluted) · EPS TTM $0.93 · revenue TTM $676.8M · FCF TTM $135.4M
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Cheap vs Health Care on P/E, EV/EBITDA
P/E 16th · EV/EBITDA 4th percentile in the Health Care pool — placement read per multiple; the API emits no single blended figure, so none is shown.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| P/E | 7.9x | 24.4x | 13.0x–39.3x | 16 ↓cheap |
| EV/EBITDA | 3.8x | 15.1x | 9.8x–24.4x | 4 ↓cheap |
| FCF Yield | 41.6% | -7.8% | -34.7%–1.4% | 99 ↑strong |
| Net Margin | 7.1% | -21.2% | -325.3%–7.2% | 75 ↑strong |
| Operating Margin | 13.5% | -34.5% | -552.0%–8.0% | 84 ↑strong |
| ROE | 10.5% | -36.8% | -92.5%–4.5% | 80 ↑strong |
